Anika Therapeutics Inc.
Company Snapshot
Founded: 1992
Entity Type: Public
Employees: 288
Region: U.S.
Revenue: $119.9 Millions
Revenue Year: 2024
Segment: OA Pain Management
Headquarter: Massachusetts, U.S.
Key Geographics: U.S., Europe
Corporate Address: 32 Wiggins Avenue, Bedford, Massachusetts 01730 U.S. Tel. +1-781-457-9000 www.anika.com
Company Overview
Anika Therapeutics and its subsidiaries offer ortho biologics, dermal, surgical, and hyaluronic acid solutions. Anika Therapeutics specializes in viscosupplement injectables for osteoarthritis pain management under the brand names Orthovisc, Monovisc, and Cingal. The company markets products through its distribution network and partners such as DePuy Synthes Mitek Sports Medicine, Boehringer Ingelheim Vetmedica, Medline Industries, Medtronic, Nordic Pharma, and Green Cross Corp.
Financial Highlights (FY 2024)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Anika Therapeutics Inc. In News
Company's Business Segments
- OEM Channel : Development and Manufacturing of products sold to OEM partners.
- Commercial Channel : Regenerative Solutions and international OA Pain Management businesses.
Applications/End User Industries
- Clinicians
- Surgeons
- Hospitals
- Sports Medicine
- Medical Care Delivery
- Monovisc
- Orthovisc
- Pain Management Products
- Regenerative Solutions
- Bone Substitute
BCC Research Beacon 